Your browser doesn't support javascript.
loading
The Presence of an In Situ Component on Pre-Treatment Biopsy Is Not Associated with Response to Neoadjuvant Chemotherapy for Breast Cancer.
Labrosse, Julie; Morel, Charlotte; Lam, Thanh; Laas, Enora; Feron, Jean-Guillaume; Coussy, Florence; Lae, Marick; Reyal, Fabien; Hamy, Anne-Sophie.
Afiliação
  • Labrosse J; Department of Surgery, Institut Curie, 75005 Paris, France.
  • Morel C; Department of Surgery, Institut Curie, 75005 Paris, France.
  • Lam T; Department of Gynecology and Obstretrics, Hôpitaux Universitaires de Genève, 1205 Geneva, Switzerland.
  • Laas E; Department of Surgery, Institut Curie, 75005 Paris, France.
  • Feron JG; Department of Surgery, Institut Curie, 75005 Paris, France.
  • Coussy F; Medical Oncology Department, Centre René Hughenin, 92210 Saint Cloud, France.
  • Lae M; Department of Tumor Biology, Institut Curie, 75005 Paris, France.
  • Reyal F; Department of Surgery, Institut Curie, 75005 Paris, France.
  • Hamy AS; Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, 75248 Paris, France.
Cancers (Basel) ; 13(2)2021 Jan 10.
Article em En | MEDLINE | ID: mdl-33435265
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article